$48.74 -2.05 (%) Ligand Pharmaceuticals Inc - NASDAQ

Sep. 19, 2014 | 04:00 PM

Partner Headlines

  1. Stocks To Watch For August 12, 2014

    Benzinga | Aug. 12, 2014 | 04:04AM EST
  2. Exclusive: Emmanuel Lemelson Talks Ligand Pharmaceuticals

    Benzinga | Aug. 7, 2014 | 13:57PM EST
  3. Ligand Pharmaceuticals Reports Earnings; Lemelson Capital Adds To Short Position

    Benzinga | Aug. 4, 2014 | 15:45PM EST
  4. Earnings Scheduled For August 4, 2014

    Benzinga | Aug. 4, 2014 | 05:14AM EST
  5. Fed Says Districts Were Optimistic On Economic Outlook; Yahoo! Falls On Downbeat Results

    Benzinga | Jul. 16, 2014 | 15:57PM EST
  6. Yahoo Falls On Downbeat Results; Time Warner Shares Spike Higher

    Benzinga | Jul. 16, 2014 | 13:36PM EST
  7. Benzinga's Volume Movers

    Benzinga | Jun. 24, 2014 | 10:41AM EST
  8. Ligand to Present Positive Data from Phase 1 Study of Effect of SERN Lasofoxifene

    Benzinga | Jun. 23, 2014 | 08:03AM EST
  9. Shares Of Ligand Follow Parabolic Curve Amid Responses Surrounding Promacta's Phase III Trial

    Benzinga | Jun. 17, 2014 | 12:26PM EST
  10. Ligand Pharmaceuticals - Severe competitive threat to key royalty program and "going ...

    GuruFocus | Jun. 16, 2014 | 18:37PM EST
  11. Indexes End With Small Gains; Tesla Drives Higher

    IBD | Jun. 16, 2014 | 16:25PM EST
  12. UPDATE: Ligand Signs Research and Licensing Agreement with Omthera Pharmaceuticals for Dyslipidemia-related Diseases

    Benzinga | May. 14, 2014 | 08:35AM EST
  13. UPDATE: Ligand Pharma Announces Milestone from Sage Therapeutics for SAGE-547

    Benzinga | May. 12, 2014 | 08:05AM EST
  14. Spectrum Pharmaceuticals' Pivotal Trial of Captisol-Enabled (Propylene Glycol-Free) Melphalan Meets Primary Endpoint

    Benzinga | Apr. 23, 2014 | 07:12AM EST
  15. UPDATE: MLV & Co Reiterates on Ligand Pharmaceuticals Following Strong 4Q Report

    Benzinga | Feb. 13, 2014 | 08:08AM EST
  16. Stocks End Near Session Highs; Ligand, Regeneron Jump

    IBD | Feb. 11, 2014 | 16:24PM EST
  17. Ligand Pharmaceuticals Poised For Full-Year Profit

    IBD | Jan. 13, 2014 | 17:44PM EST
  18. UPDATE: Cantor Fitzgerald Raises PT on Ligand Pharmaceuticals as Key Partnered Program Advances

    Benzinga | Dec. 10, 2013 | 12:34PM EST
  19. Ligand Pharmaceuticals Sees Q4 EPS $0.31-$0.32 vs $0.22-$0.24; Q4 Revenue $14.0M-$14.5M vs $11.0M-$12.0M

    Benzinga | Dec. 4, 2013 | 05:57AM EST
  20. A Few Stocks Form Bases, But Have Flaws

    IBD | Nov. 20, 2013 | 18:30PM EST
  21. Ligand Pharmaceuticals On Pace For Annual Profit

    IBD | Nov. 5, 2013 | 17:25PM EST
  22. Ligand, NIC: Thinly Traded Stocks That Hold Promise

    IBD | Oct. 24, 2013 | 17:17PM EST
  23. Ligand Partner GSK Receives Marketing Authorization from EC for Additional Revolade Indication as Treatment for Chronic Hepatitis C-Associated Thrombocytopenia

    Benzinga | Sep. 24, 2013 | 07:06AM EST
  24. Ligand Enters Global License Agreement with CURx Pharmaceuticals for Captisol-Enabled Topiramate Injection

    Benzinga | Aug. 14, 2013 | 08:04AM EST
  25. Ligand Receives FDA Orphan Designation for Captisol-Enabled Topiramate Injection

    Benzinga | Jul. 26, 2013 | 06:37AM EST
  26. UPDATE: Cantor Fitzgerald Downgrades Ligand Pharmaceuticals to Hold, Lowers PT

    Benzinga | Jan. 4, 2013 | 01:38AM EST
  27. FDA Accepts NDA for Pfizer, Ligand's Bazedoxifene/Conjugated Estrogens

    Benzinga | Dec. 13, 2012 | 10:05AM EST
  28. Ligand Pharma Begins Pivotal Trial of Captisol-Enabled Propylene Glycol-Free Melphalan for Multiple Myeloma Patients

    Benzinga | Dec. 10, 2012 | 09:09AM EST
  29. Ligand Pharmaceuticals, Inc. (LGND) CEO John L Higgins buys 2,000 Shares

    GuruFocus | Dec. 5, 2012 | 11:06AM EST
  30. Benzinga's Volume Movers

    Benzinga | Nov. 19, 2012 | 03:46AM EST
  31. Ligand Pharma, Glaxo Confirm PROMACTA Receives FDA Ok for New Indication

    Benzinga | Nov. 19, 2012 | 02:11AM EST
  32. Ligand Pharmaceuticals Inc. Reports Operating Results (10-K/A)

    GuruFocus | Nov. 14, 2012 | 09:06AM EST
  33. Ligand Pharmaceuticals Inc. Reports Operating Results (10-Q/A)

    GuruFocus | Nov. 14, 2012 | 09:06AM EST
  34. Ligand Pharmaceuticals Inc. Reports Operating Results (10-Q/A)

    GuruFocus | Nov. 14, 2012 | 09:06AM EST
  35. Ligand Pharmaceuticals Inc. Reports Operating Results (10-Q)

    GuruFocus | Nov. 14, 2012 | 09:06AM EST
  36. Ligand Pharma Announces Preclinical Data for LG-7501

    Benzinga | Nov. 13, 2012 | 02:08AM EST
  37. Ligand to Receive $2 Million Milestone Payment from Merck; Re-Affirms FY Forecast

    Benzinga | Oct. 22, 2012 | 02:31AM EST
  38. Ligand Pharmaceuticals Inc. Reports Operating Results (10-Q)

    GuruFocus | Aug. 8, 2012 | 14:29PM EST
  39. Ligand Partner GlaxoSmithKline Announces Priority Review for Supplemental New Drug Application for Promacta® for the Treatment of Thrombocytopenia in Adult Patients with Chronic Hepatitis C Infection

    Benzinga | Jul. 25, 2012 | 01:16AM EST
  40. One Drugmaker Soars, 1 Falls

    IBD | Jun. 21, 2012 | 13:25PM EST
  41. Onyx Up, Celgene Down On Cancer Drug News

    IBD | Jun. 21, 2012 | 13:02PM EST
  42. ConAgra Foods, HONDA MOTOR CO. Among Stocks Up on High Volume Thursday

    FoxBusiness | Jun. 21, 2012 | 06:33AM EST
  43. Ligand Pharmaceuticals Inc. Reports Operating Results (10-K)

    GuruFocus | Feb. 23, 2012 | 11:10AM EST
  44. Ligand Pharmaceuticals Inc. Reports Operating Results (10-Q/A)

    GuruFocus | Feb. 10, 2012 | 11:37AM EST
  45. Ligand Pharmaceuticals Inc. Reports Operating Results (10-Q/A)

    GuruFocus | Feb. 10, 2012 | 11:37AM EST
  46. Ligand Pharmaceuticals Inc. Reports Operating Results (10-Q/A)

    GuruFocus | Feb. 10, 2012 | 10:36AM EST
  47. MLV & Co Affirms Ligand Pharmaceuticals Buy, $30 PT

    Benzinga | Feb. 8, 2012 | 09:18AM EST
Trading Center